Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

198 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S La catégorie “autres antibiotiques” est constituée de tous les antibiotiques « moins » ceux appartenant à une des catégories précisées dans ce tableau. En pratique, il s’agit des des mero- et imi-penems, des lincosamides, des aminosides, des phénicols, des glycopeptides, des imidazolés et des combinaisons d’antibiotiques. Il faut toutefois se souvenir de ce que nous n’analysons ici que les médicaments mis à disposition en ambulatoire. Codes CNK pour rechercher les sirops et solutions d’antibiotiques:
KCE Reports 85 S Médecine à l'acte : médecine au forfait - ANNEXES 199 code ATC conditionnement principe actif code CNK J01BA01 CHLOROMYCETINE PALM SIR 1 chloramphenicol 106054 J01CA01 PENBRITIN FORT SIR 1X80ML ampicillin 67033 J01CA01 PENBRITIN PULV SIR 1X60ML ampicillin 124354 J01CA01 PENTREXYL HD 1 X 80 ML 2 ampicillin 124602 J01CA04 AMOXI 500 PULV OR 16 X 5 amoxicillin 433730 J01CA04 AMOXI-250 FL 1 X 80 ML 2 amoxicillin 868604 J01CA04 AMOXICILLINE SIR 1 X 80ML amoxicillin 671297 J01CA04 AMOXICILLINE SIR 80 ML 25 amoxicillin 1357995 J01CA04 AMOXIPHAR SIR 80 ML 250MG amoxicillin 1226075 J01CA04 AMOXYPEN SIR PULV 1X80ML amoxicillin 688184 J01CA04 CLAMOXYL PULV 16 X 250 MG amoxicillin 107201 J01CA04 CLAMOXYL PULV 16 X 500 MG amoxicillin 107219 J01CA04 CLAMOXYL SIR 1 X 80 ML 12 amoxicillin 107342 J01CA04 CLAMOXYL SIR 1 X 80 ML 25 amoxicillin 107359 J01CA04 DOCAMOXICI PULV SUSP 80ML amoxicillin 1487156 J01CA04 FIMOXIL PULV OR 16 X 500 amoxicillin 861765 J01CA04 FLEMOXIN 80ML PULV SUSP O amoxicillin 1027614 J01CA04 HICONCIL SUSP OR 1 X 80ML amoxicillin 47613 J01CA04 MOXALINE PULV SUSP 1X80ML amoxicillin 57802 J01CA04 NOVABRITINE SIR 1 X 80ML amoxicillin 121954 J01CA04 NOVABRITINE SIR 1 X 80ML amoxicillin 122036 J01CE02 PENI-ORAL SOL 1X120ML 20 phenoxymethylpenicillin 124446 J01CE10 ORACILLINE SUSP OR 1X120M benzathine phenoxymethylpenicillin 64121 J01CF02 ORBENIN PULV SIR 1 X 60ML cloxacillin 123034 J01CF02 PENSTAPHO N SIR 1 X 80ML cloxacillin 120808 J01CF05 FLOXAPEN SIR FL 80 ML 25 flucloxacillin 263707 J01CF05 STAPHYCID SUSP OR 80ML 25 flucloxacillin 263731 J01CF05 STAPHYCID SUSP PER OS 80 flucloxacillin 263723 J01CR02 AMOXICLAV BC 125MG/5ML PD amoxicillin and enzyme inhibitor 1541440 J01CR02 AMOXICLAV BC 125MG/5ML PD amoxicillin and enzyme inhibitor 1541457 J01CR02 AMOXICLAV BC 250MG/5ML PD amoxicillin and enzyme inhibitor 1541465 J01CR02 AMOXICLAV BC 250MG/5ML PD amoxicillin and enzyme inhibitor 1541549 J01CR02 AUGMENTIN SIR 1X80ML 125M amoxicillin and enzyme inhibitor 33548 J01CR02 AUGMENTIN SIR 1X80ML 250M amoxicillin and enzyme inhibitor 34637 J01CR02 CLAVUCID PULV SIR 80 ML 2 amoxicillin and enzyme inhibitor 263681 J01CR02 CO AMOXI RATIOPH 125 SUSP amoxicillin and enzyme inhibitor 1543669 J01CR02 CO AMOXI RATIOPH 250 SUSP amoxicillin and enzyme inhibitor 1543685 J01CR02 CO AMOXILAN EG SIR. 125MG amoxicillin and enzyme inhibitor 1692102 J01CR02 CO AMOXILAN EG SIR. 250MG amoxicillin and enzyme inhibitor 1692128 J01CR02 MERCK AMOXICLAV 125MG/5ML amoxicillin and enzyme inhibitor 1584291 J01CR02 MERCK AMOXICLAV 250MG/5ML amoxicillin and enzyme inhibitor 1584309 J01DB01 KEFORAL SUSP OR 1X80ML 25 cefalexin 117283 J01DB05 DURACEF SUSP OR 1X80ML 2 cefadroxil 838276 J01DB05 DURACEF SUSP PER OS 80ML cefadroxil 1204965 J01DC02 AXETINE 250 MG/5 ML SUSP cefuroxime 1744010 J01DC02 ZINNAT 250 SUSP OR 50ML cefuroxime 1531433 J01DC02 ZINNAT 250 SUSP OR 100ML cefuroxime 1531441 J01DC04 CECLOR SUSP OR 1 X 60 ML cefaclor 664136 J01DC04 CECLOR SUSP OR 1 X 60 ML cefaclor 818914 J01DC04 CECLOR SUSP OR 100ML 250M cefaclor 1152115 J01DC04 DOCCEFACLO SIR 60 ML 250 cefaclor 1533900 J01DC04 DOCCEFACLO SIR 100 ML 250 cefaclor 1533892 J01DC04 FACLORTOP SUSP OR 250MG/5 cefaclor 1699131
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
KCE Reports 85 S Médecine à l'act
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152: KCE Reports 85 S Médecine à l'act
Page 201: KCE Reports 85 S Médecine à l'act
Page 245 and 246: This page is left intentionally bla
Page 247 and 248: KCE reports 1. Efficacité et renta
Page 249: 74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?